Article
Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis.
PloS one - 1 Jan 2014
Cronin-Fenton Deirdre P, Christensen Mariann, Lash Timothy L, Ahern Thomas P, Pedersen Lars, Garne Jens Peter, Ewertz Marianne, Autrup Herman, Sørensen Henrik T, Hamilton-Dutoit Stephen
Abstract excerpt
BACKGROUND: Manganese superoxide dismutase (MnSOD) inhibits oxidative damage and cancer therapy effectiveness. A polymorphism in its encoding gene (SOD2: Val16Ala rs4880) may confer poorer breast cancer survival, but data are inconsistent. We examined the association of SOD2 genotype and breast cancer recurrence (BCR) among patients treated with cyclophosphamide-based chemotherapy (Cyclo). We compared our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
